As of May 26
| +0.76 / +1.73%|
The 15 analysts offering 12-month price forecasts for Abbott Laboratories have a median target of 48.00, with a high estimate of 52.00 and a low estimate of 43.00. The median estimate represents a +7.36% increase from the last price of 44.71.
The current consensus among 19 polled investment analysts is to Buy stock in Abbott Laboratories. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.